CBWD6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.617000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.106600E-01
Normal-vs-Stage2
7.724400E-01
Normal-vs-Stage3
1.916420E-01
Normal-vs-Stage4
6.084600E-01
Stage1-vs-Stage2
5.760800E-01
Stage1-vs-Stage3
1.162820E-01
Stage1-vs-Stage4
4.786400E-01
Stage2-vs-Stage3
2.198400E-02
Stage2-vs-Stage4
8.972400E-01
Stage3-vs-Stage4
8.348000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.344400E-01
Normal-vs-AfricanAmerican
4.842800E-01
Normal-vs-Asian
8.349400E-01
Caucasian-vs-AfricanAmerican
5.616600E-01
Caucasian-vs-Asian
4.353600E-01
AfricanAmerican-vs-Asian
3.859400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.001200E-01
Normal-vs-Female
7.145000E-01
Male-vs-Female
7.312600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.777000E-01
Normal-vs-Age(41-60Yrs)
9.205200E-01
Normal-vs-Age(61-80Yrs)
7.270200E-01
Normal-vs-Age(81-100Yrs)
3.130200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.408000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.664000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.951400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.096200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.190800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.897800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.004800E-01
Normal-vs-Daily Drinker
4.961800E-01
Normal-vs-Weekly Drinker
5.210800E-01
Normal-vs-Occasional Drinker
7.335400E-01
Normal-vs-Social Drinker
5.176400E-01
Non Drinker-vs-Daily Drinker
6.627800E-01
Non Drinker-vs-Weekly Drinker
7.468000E-01
Non Drinker-vs-Occasional Drinker
9.146800E-01
Non Drinker-vs-Social Drinker
6.788600E-01
Daily Drinker-vs-Weekly Drinker
9.547200E-01
Daily Drinker-vs-Occasional Drinker
6.010800E-01
Daily Drinker-vs-Social Drinker
9.658600E-01
Weekly Drinker-vs-Occasional Drinker
6.786000E-01
Weekly Drinker-vs-Social Drinker
9.285000E-01
Occasional Drinker-vs-Social Drinker
6.205600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.601600E-01
Normal-vs-Grade 2
9.154200E-01
Normal-vs-Grade 3
9.240000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.850400E-01
Grade 1-vs-Grade 3
6.524600E-01
Grade 1-vs-Grade 4
9.601600E-01
Grade 2-vs-Grade 3
9.526400E-01
Grade 2-vs-Grade 4
9.154200E-01
Grade 3-vs-Grade 4
9.240000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.442000E-01
Normal-vs-NonDiabetic
8.622000E-01
Diabetic-vs-NonDiabetic
6.748400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.496600E-01
Normal-vs-NoPancreatitis
8.288200E-01
Pancreatitis-vs-NoPancreatitis
7.559800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.789200E-01
Normal-vs-N1
7.324600E-01
N0-vs-N1
5.024400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.323400E-01
Normal-vs-TP53-NonMutant
8.867000E-01
TP53-Mutant-vs-TP53-NonMutant
8.909600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
